Wixela vs Pulmicort
What to choose Wixela or Pulmicort
Wixela is inhaler of type Control while Pulmicort is of Rescue type. Wixela and Pulmicort are both brand inhalers. Wixela is manufactured by pharmaceutical company Viatris, while Pulmicort is manufactured by AstraZeneca. The main substances of Wixela are Fluticasone and Salmeterol. The available dosage for Wixela is 250/50. The main substance of Pulmicort is Budesonide. The available dosages for Pulmicort are 180 mcg, 90 mcg.
The average price for Wixela is approximately $240 per inhaler while average cost for Pulmicort is approximately $281 per inhaler, said Brodie Cook, an Assistant Professor at the Drake University and a Patient Representative at a clinic that uses Wixela and Pulmicort.
Wixela and Pulmicort Comparison
|Substance:||Fluticasone + Salmeterol||Budesonide|
|Dosage:||250/50||180 mcg, 90 mcg|